Extemporaneously prepared controlled release formulations for accelerating the early phase development of drug candidates

- We describe the extemporaneous preparation of matrix tablets and osmotic capsules.
- They can be used rapidly to assess the feasibility of controlled release in humans.
- Two case studies demonstrate how they can help decision-making during drug development.